3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Overall Survival
1
Melanoma
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Heart Diseases
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Interventions
Doxorubicin
5
Cyclophosphamide
3
Trastuzumab
2
Docetaxel
2
Dexrazoxane
2
empagliflozin
1
Taxes
1
Tamoxifen
1
Razoxane
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
Neoadjuvant Therapy
1
Methotrexate
1
Metformin
1
Leucovorin
1
High-Intensity Interval Training
1
Hematologic Tests
1
Filgrastim
1
Exercise
1
Epirubicin
1
Echocardiography
1
Cisplatin
1
Chemotherapy, Adjuvant
1
Carvedilol
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Cardiotoxicity
×
Atorvastatin
×
Clear all
NCT02674204
2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2
Terminated
2 enrolled
7 charts